Target intelligence / Profile preview

RecQ-mediated genome instability protein 2 (RMI2)

Target
RMI2
Molecular classification
Accessory protein, OB-fold (Oligonucleotide/oligosaccharide-binding) family protein, DNA repair complex subunit, Scaffold protein
01

Overview

RecQ-mediated genome instability protein 2 (RMI2) is a small, evolutionarily conserved accessory protein within the BLM complex (consisting of BLM helicase, Topoisomerase IIIα, RMI1, and RMI2). RMI2 contains a single OB-fold, enabling protein-protein interactions rather than direct nucleic acid binding. Its critical function is to stabilize the BLM complex by interacting with RMI1 via hydrophobic and electrostatic contacts, enabling the dissolution of double Holliday junction intermediates—key DNA repair events that suppress crossovers and maintain chromosomal stability. It is required for proper mitotic and meiotic recombination, suppresses inappropriate sister chromatid exchange, and is essential for preventing genome instability. Loss or mutation of RMI2 (or BLM complex disruption) is linked to increased genome instability and the cancer-prone disorder Bloom syndrome[1][2][3][5].

Other names
BLM-associated protein of 18 kDaC16orf75hRMI2BLAP18MGC24665RecQ mediated genome instability 2, homologRMI2_HUMANQ96E14
02

Biological functions

Genome stability maintenanceHomologous recombinationSuppression of sister chromatid exchangeDouble Holliday junction dissolutionStabilization and localization of BLM complexProtein-protein interaction mediation within the BTR complex (BLM-TOP3A-RMI1-RMI2)
03

Disease associations

CancerBloom syndrome
04

Safety considerations

Genome instability risk with inhibition or loss; impaired DNA repair can predispose to cancer or chromosomal abnormalities

Beyond the preview

Go deeper on RecQ-mediated genome instability protein 2 (RMI2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RecQ-mediated genome instability protein 2 (RMI2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call